CGM Use in COVID19 Patients (Infection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2))

Clinical trial NCT04756141 · COMPLETED

Trial details

NCT number: NCT04756141
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Diabetes Mellitus Covid19

Start date: 2021-03-03
Primary completion: 2022-08-24
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.